Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe-Frithjof Haustein

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
European Journal of Dermatology : EJD|January 26, 2002
Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantationPietro Nenoff, Constanze Kliem, Matthias Mittag, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)Anne Wetzel, Triantafyllos Chavakis, Klaus T Preissner, et al.
Experimental Dermatology|August 16, 2005
MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokinesUlf Anderegg, Kerstin Breitschwerdt, Martin J Köhler, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
European Journal of Dermatology : EJD|January 26, 2002
Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantationPietro Nenoff, Constanze Kliem, Matthias Mittag, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)Anne Wetzel, Triantafyllos Chavakis, Klaus T Preissner, et al.
Experimental Dermatology|August 16, 2005
MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokinesUlf Anderegg, Kerstin Breitschwerdt, Martin J Köhler, et al.
Pageof 3